Lysis and Absorption of Fibrin Sealant (Tissucol/Tisseel)

In Vitro and In Vivo Experiments
  • H. Pflüger
Conference paper

Abstract

In order to determine the optimal fibrin thrombin adhesive system (FTAS) composition for resistance to fibrinolysis, in vivo lysis was tested by adding increasing amounts of the fibrinolysis inhibitor aprotinin to 125I-FS; urokinase and plasminogen were administered in vitro while measuring protein and iodine125 release. The correlation between protein and iodine125 release clearly reflects the interdependence of these parameters; disjunction of radioactivity from the protein molecule was ruled out. In vivo, fibrinolysis is inhibited to a nearly unlimited extent by aprotinin. In vivo, aprotinin improves fibrinolysis inhibition only up to a maximum of 1500 KIU/ml clot, thereby significantly altering the maximum elimination of 125iodine and FS half-life as well. Higher doses of aprotinin applied in vivo remain without effect upon FS stability. In human surgery, the addition of aprotinin to FS is recommended for strictly hemostatic application only, not for tissue synthesis such as nerve and micro vessel anastomoses in plastic reconstructive surgery.

The aim of the second study was to investigate the degradation of fibrinogen thrombin adhesive system (FTAS) and the process of wound healing after partial kidney resection in rats using FTAS for induction of local hemostasis. In 28 rats partial kidney resection was performed bilaterally. Hemostasis was achieved with FTAS. Four experimental groups were formed. Group F (n = 3): hemostasis with unlabeled FTAS, subcutaneous injection of 0.1 ml = 60 μCi Na 125I. Group G (n = 3): hemostasis with unlabeled FTAS, subcutaneous injection of 0.1 ml = 60 μCi 125I-labeled FTAS, Group H (n = 6): hemostasis with 125Mabeled FTAS. Group I (n = 16): treated like group H. In groups F-H 125I elimination in 24-h urine samples was determined with a gamma-scintillation counter. Pairs of animals in group I were killed after 2, 6, 12, and 24 h and 3, 7, 14, and 21 days.

Kidneys were examined under the light and electron microscope and by autoradiography. In animals of groups G and H two peaks of 125I excretion were observed: one peak within the first 48 h postoperatively which corresponded to the amount of free iodine injected with FTAS (FTAS contains 15% free iodine) and a second peak after 120 h which was most probably due to the degradation of FTAS. Fibrinolysis was not observed. FTAS was resorbed mainly by macrophages. The time course of wound healing paralleled that of physiological fibrinogen concentration. Renal parenchymal damage was not observed.

Key words

Fibrin wound repair fibrinolysis 125I-elimination 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alkjaersing N, Fletscher AP, Sherry S (1959) The mechanism of clot dissolution by plasmin. Journal of Clinical Investigation 38, 1068Google Scholar
  2. 2.
    Bösch P, Braun F, Eschberger J, Kovac W, Spängier HP (1977) The action of high-concentrated fibrin on one healing. Archiv für Orthopädie und Unfallchirurgie 89, 259Google Scholar
  3. 3.
    Braun F, Henning K, Holle J, Kovac W, Rauchenwald K, Spängier HP, Urlesberger H (1977) A biological adhesive system (Fibrin) in partial kidney resection. Zentralblatt für Chirurgie 102, 1235PubMedGoogle Scholar
  4. 4.
    Dudock de Wit C, Krijinen HW, den Ottolander GJH (1962) The measurement of fibrinolytic activity with I131-labeled clots I. The methods. Thrombosis and Haemostatis (Stuttgart) 8, 315Google Scholar
  5. 5.
    Dudock de Wit C, Krijinen HW, den Ottolander GJH (1972) The measurement of fibrinolytic activity with 131I-labeled clots II. Application. Thrombosis and Haemostatis (Stuttgart) 8, 322Google Scholar
  6. 6.
    Guttmann J (1978) Untersuchungen eines Fibrinklebers für die Anwendung in der Chirurgie peripherer Nerven. Diplomarbeit, Inst f Botanik, Techn Mikroskopie und Organ Rohstofflehre. Techn Univ WienGoogle Scholar
  7. 7.
    Jennings MA, Florey HW (1970) Healing. In: General pathology. Florey L (ed.), Chapter 17, p. 480. Oxford: Lloyd-LucesGoogle Scholar
  8. 8.
    Kay AB, Pepper DS, Ewart MR (1973) Generation of chemotactic activity for leukocytes by the action of thrombin on human fibrinogen. Nature 243:56–57CrossRefGoogle Scholar
  9. 9.
    Maunsbach AB (1966) The influence of different fixatives and fixation methods on the ultrastructure of rat kidney proximal tubule cells. I. Comparison of different perfusion fixation methods and of gluteraldehyde, formaldehyde and osmium tetroxide fixatives. Journal of Ultrastructure Research 15, 242PubMedCrossRefGoogle Scholar
  10. 10.
    Pflüger H, Lunglmayr G, Breitenecker G (1976) Anastomosis of the vas deferense employing concentrated fibrinogen: a experimental study in rabbits. Wiener klinische Wochenschrift 88, 24, 800PubMedGoogle Scholar
  11. 11.
    Redl H, Schlag G, Dinges H, Kuderna H, Seelich T (1982) Background and methods of “fibrin sealing”. In: Biomaterials (Winter D, Gibbons DF, Plenk H eds.), John Wiley and Sons, Ltd. Chichester, 669–676Google Scholar
  12. 12.
    Spängier HP (1978) Tissue adhesion and local hemostasis using fibrinogen, thrombin and clotring factor XIII. (Experimental investigation — Clinical experience) Wiener klinische Wochenschrift 88, Suppl 49Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • H. Pflüger

There are no affiliations available

Personalised recommendations